Stock REPCF REPLICEL LIFE SCIENCES INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart RepliCel Life Sciences Inc.

Equities

REPCF

CA76027P4006

Market Closed - OTC Markets
Other stock markets
 11:20:42 2024-03-15 am EDT 		5-day change 1st Jan Change
0.0428 USD +4.99% Intraday chart for RepliCel Life Sciences Inc. -.--% -4.89%
Apr. 18 RepliCel Life Sciences Inc. Announces Secured Loan Agreement CI
2023 RepliCel Life Sciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
REPLICEL LIFE SCIENCES INC. Stock RepliCel Life Sciences Inc.
 2.78M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 111B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
 106B
BIONTECH SE Stock BioNTech SE
 22.24B -
ARGENX SE Stock argenx SE
 21.25B -
GENMAB A/S Stock Genmab A/S
 18.97B
  1. Stock Market
  2. Equities
  3. REPCF Stock
  4. Charts RepliCel Life Sciences Inc.
  5. Sector Chart
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW